The role of neuropeptides in modulating PRL and GH secretion.
D000818:Animals; D001839:Bombesin / Q000494:pharmacology; D002766:Cholecystokinin / Q000494:pharmacology; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D009419:Nerve Tissue Proteins / Q000502:physiology*; D009479:Neuropeptides / Q000502:physiology*; D009496:Neurotensin / Q000494:pharmacology / Q000502:physiology; D018377:Neurotransmitter Agents; D010121:Oxytocin / Q000494:pharmacology / Q000502:physiology; D010904:Pituitary Gland, Posterior / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D011389:Prolactin Release-Inhibiting Factors; D051381:Rats; D011957:Receptors, Opioid / Q000502:physiology; D013373:Substance P / Q000494:pharmacology / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology / Q000502:physiology
D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D011957:Receptors, Opioid; D014667:Vasopressins; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin; D010121:Oxytocin; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013006:Growth Hormone; D002766:Cholecystokinin; D011389:Prolactin Release-Inhibiting Factors; D001839:Bombesin